TAKAYASU ARTERITIS

Clinical trials for TAKAYASU ARTERITIS explained in plain language.

Never miss a new study

Get alerted when new TAKAYASU ARTERITIS trials appear

Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 3 Completed 4 Terminated 1

Experimental cell therapy takes on stubborn autoimmune diseases

Disease control Terminated

This early study tested a new cell therapy called LUCAR-G79 in just 3 adults with severe autoimmune diseases that did not respond to standard treatments. The therapy uses specially engineered immune cells to target and potentially calm the overactive immune system. The main goals…

Matched conditions: TAKAYASU ARTERITIS

Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

TAKAYASU ARTERITIS

Get alerted when new TAKAYASU ARTERITIS trials appear

Experimental cell therapy takes on stubborn autoimmune diseases